Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions
Retrieved on:
Tuesday, January 12, 2021
The new hearing date is set for September 6, 2021.
Key Points:
- The new hearing date is set for September 6, 2021.
- On January 29, 2018, the Opposition Division of the EPO concluded the oral proceedings concerning the 355 Patent (the Opposition Proceeding).
- Management expects the TBA to issue a ruling on the same day as the hearing, with a fully reasoned decision approximately two months following the hearing.
- The denial of a request to rehear would end the Opposition Proceeding in favor of the opponents.